Clinical Trial Update: MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cisplatin in combination with gemcitabine for elderly patients with non-small cell lung cancer (metastatic or stage IIIB).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cisplatin/Gemcitabine

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Non-small Cell Lung Cancer Metastatic, Non-small Cell Lung Cancer Stage IIIB | Phase 3 | Status: UNKNOWN